Human babesiosis in Europe.
Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 microns) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varied from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycin (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention.
Brasseur
P
P
Laboratoire de Parasitologie, Centre Hospitalier Universitaire, Rouen, France.
Gorenflot
A
A
D058186:Acute Kidney Injury / Q000209:etiology / Q000517:prevention & control; D001404:Babesiosis / Q000453:epidemiology* / Q000469:parasitology / Q000628:therapy; D004198:Disease Susceptibility; D004630:Emergencies; D005060:Europe / Q000453:epidemiology; D006801:Humans; D011183:Postoperative Complications / Q000469:parasitology; D013156:Splenectomy